Diphenadione: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 26: | Line 26: | ||
{{Chem-stub}} | {{Chem-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
<gallery> | |||
File:Diphenadione2.svg | |||
File:Diphenadione_3D_ball.png | |||
</gallery> | |||
Latest revision as of 01:47, 17 February 2025
Diphenadione is a vitamin K antagonist and an anticoagulant, which is often used as a rodenticide. It is a second-generation derivative in the family of coumarin-based anticoagulants. Diphenadione was first registered in the United States in 1953.
Mechanism of Action[edit]
Diphenadione exerts its anticoagulant properties by inhibiting the vitamin K epoxide reductase enzyme. This enzyme is responsible for the recycling of vitamin K in the body. By inhibiting this enzyme, Diphenadione disrupts the blood clotting process, leading to uncontrolled bleeding and eventual death in rodents.
Uses[edit]
Diphenadione is primarily used as a rodenticide. It is effective against a variety of rodents including rats, mice, and squirrels. It is often used in situations where first-generation anticoagulants have failed due to resistance.
Toxicity[edit]
Diphenadione is highly toxic to mammals and birds, and slightly toxic to fish and aquatic invertebrates. It is classified as a Category C, possible human carcinogen. Exposure to Diphenadione can lead to a variety of symptoms including nausea, vomiting, abdominal pain, and bleeding.
Treatment[edit]
Treatment for Diphenadione poisoning involves discontinuing exposure to the substance and administering vitamin K1 therapy. In severe cases, blood transfusion may be necessary.
See Also[edit]
References[edit]
<references />

